US government to distribute monkeypox vaccines – RT World News

The White House will distribute nearly 2 million monkeypox vaccines in the coming months, starting with an initial phase of about 300,000 doses as part of a new national strategy against the potentially dangerous virus.

The White House announced the strategy Tuesday, noting that 56,000 vaccine doses would be assigned immediately, followed by 240,000 additional shots. “the coming weeks.” An additional 1.6 million doses will be available later this year.

“The vaccine strategy will help address the spread of the virus immediately by providing vaccines nationwide to high-risk individuals,” the White House said, adding that the first leg of the plan “focuses on rapidly deploying vaccines in the most affected communities and reducing the spread of the disease.”

The government also said 32 states and jurisdictions had so far requested vaccines and deployed more than 9,000 doses and 300 antiviral treatments. On Tuesday, the Centers for Disease Control and Prevention (CDC) said it had confirmed a total of 305 cases of monkeypox in the US, while more than 4,400 have been discovered abroad.


US buys millions of vaccine doses for dangerous virus

In addition to handing out hundreds of thousands of vaccines, the White House said it would? “dramatically expand” monkey pox testing across the country, after the CDC began shipping approved test kits to several major commercial labs. To further improve availability, the CDC has published its protocol for the tests, which can be used by third-party labs without FDA authorization.

Health agencies signed a multi-million dollar deal in May, agreeing to buy up to 13 million doses of the Jynneos vaccine from Danish pharmaceutical company Bavarian Nordic. It was originally created for smallpox, but was approved by the FDA in 2019 for use against monkeypox. However, the final contract won’t be fulfilled until next year, meaning the White House will have to rely on existing supplies.

To complement the supply of the Jynneos vaccine, another inoculation, ACAM2000, will also be available for states and territories. Like Jynneos, ACAM2000 was developed for smallpox but has been approved for dual use, although the White House warned that the latter “carries a greater risk of certain serious side effects” for people with pre-existing heart and immune conditions.

Though rare, monkeypox has been previously discovered in the US, with a Texas resident hospitalized last summer for the virus after traveling to West Africa, where the pathogen is endemic. More than 70 cases were confirmed in the US in 2003, which was the first outbreak outside of Africa, according to the World Health Organization.

The first symptoms are fever, headache and muscle aches, swollen lymph nodes, chills and exhaustion, and while most infections clear up without serious illness, the virus is fatal in a small percentage of cases.

READ MORE:
Top health statements on how monkey pox spreads